Aug. 15 at 8:08 AM
$ADIL It's been exactly a year since Carry announced at least 3 times that they will start treatment at the end of 2025. The first phase of treatment phase 3 according to its announcement, would cost 7-10 million USD. Only in March or April of this year did they announce that they have drugs ready for phase 3 (ad04)... At Carry's general pace, those drugs will expire sooner and they will have to throw them away before he can even move anything forward. This person is just extending his salary from investors. He alone takes 1 million USD per year. Calculate the entire team and compare it to the price of phase 3 and the ad04 move. But they continue to dilute the shares to have payouts, but the results compared to the ad04 step do not match it.
Carry will ceremonially receive his severance pay and we will pay his health insurance for 24 months. But most importantly, let the person be gone from the CEO. 3x hooray.
